Condition
Gram Negative Infections clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Gram Negative Infections clinical trials that are recruiting, at sites in 6 countries (most in Italy (4), Spain (2), Czechia (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Gram Negative Infections clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fast antibiotic sensitivity tests to guide treatment for bloodstream infections | — | Rozzano, Milan | Recruiting | Mar 24, 2026 |
| Personalized antibiotic duration for high-risk febrile neutropenia with Gram-negative bloodstream infection | — | Rozzano, Milan | Recruiting | Jan 28, 2026 |
| Ceftazidime (±avibactam) with IV fosfomycin versus ceftazidime alone for hospitalized adults with severe suspected Gram‑negative infection | Phase 3 | Geneva, Canton of Geneva | Recruiting | Jul 14, 2025 |
| Assessing Vaborem in Children with Complicated Urinary Tract Infections | Phase 2 | Ostrava and 21 other locations | Recruiting | Feb 14, 2025 |
| Evaluating the effectiveness of CAZ/AVI and FOS for treating CRE infections | — | Bologna, Bologna and 1 other locations | Recruiting | Dec 5, 2024 |
All recruiting trials (5)
-
Fast antibiotic sensitivity tests to guide treatment for bloodstream infections
This tests whether rapid antibiotic susceptibility tests can help doctors pick the right antibiotics sooner for adults with positive blood cultures and improve recovery and antibiotic use.
-
Personalized antibiotic duration for high-risk febrile neutropenia with Gram-negative bloodstream infection
This trial tests whether stopping antibiotics after a patient with a blood cancer and febrile neutropenia has been clinically stable for 72 hours is as safe and lets them spend more days off anti–Gram-negative antibiotics than the usual at least 10-day approach.
-
Ceftazidime (±avibactam) with IV fosfomycin versus ceftazidime alone for hospitalized adults with severe suspected Gram‑negative infection
This trial will test whether adding intravenous fosfomycin to ceftazidime (or ceftazidime‑avibactam) helps hospitalized adults with suspected severe Gram‑negative infections recover faster than ceftazidime alone.
-
Assessing Vaborem in Children with Complicated Urinary Tract Infections
This study is testing if the drug Vaborem is safe and works well for children in the hospital who have complicated urinary tract infections.
-
Evaluating the effectiveness of CAZ/AVI and FOS for treating CRE infections
This study is testing whether a combination of two antibiotics, ceftazidime/avibactam and fosfomycin, can help adults with tough infections caused by drug-resistant bacteria feel better.
Related topics
Quick answers
How many Gram Negative Infections clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Italy (4 trials), Spain (2 trials), Czechia (1 trial), France (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.